Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways

被引:120
作者
Taylor, C [1 ]
Fricker, AD [1 ]
Devi, LA [1 ]
Gomes, N [1 ]
机构
[1] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
anxiety; depression; neurogenesis; SSRI; CRH; cortisol;
D O I
10.1016/j.cellsig.2004.12.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Antidepressants are commonly used in the treatment of anxiety and depression, medical conditions that affect similar to17-20% of the population. The clinical effects of antidepressants take several weeks to manifest, suggesting that these drugs induce adaptive changes in brain structures affected by anxiety and depression. In order to develop shorter-acting and more effective drugs for the treatment of anxiety and depression, it is important to understand how antidepressants bring about their beneficial effects. Recent reports suggest that antidepressants can induce neurogenesis in the adult brain, although the mechanisms involved are not clearly understood. In this review, we describe the different neurotransmitter systems that are affected by anxiety and depression and how they are modulated by antidepressant treatment with a focus on signaling molecules and pathways that are activated during neurotransmitter receptor induced neurogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 108 条
[1]   Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus [J].
Alfonso, J ;
Pollevick, GD ;
van der Hart, MG ;
Flügge, G ;
Fuchs, E ;
Frasch, ACC .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (03) :659-666
[2]   Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression [J].
Alonso, R ;
Griebel, G ;
Pavone, G ;
Stemmelin, J ;
Le Fur, G ;
Soubrié, P .
MOLECULAR PSYCHIATRY, 2004, 9 (03) :278-286
[3]  
*AM PSYCH ASS, 2002, DAIG STAT MAN MENT D
[4]   Genetics of anxiety disorders [J].
Arnold P.D. ;
Zai G. ;
Richter M.A. .
Current Psychiatry Reports, 2004, 6 (4) :243-254
[5]   Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor [J].
Barden, N ;
Stec, ISM ;
Montkowski, A ;
Holsboer, F ;
Reul, JMHM .
NEUROENDOCRINOLOGY, 1997, 66 (03) :212-220
[6]   Regulation of the norepinephrine transporter by chronic administration, of antidepressants [J].
Benmansour, S ;
Altamirano, AV ;
Jones, DJ ;
Sanchez, TA ;
Gould, GG ;
Pardon, MC ;
Morilak, DA ;
Frazer, A .
BIOLOGICAL PSYCHIATRY, 2004, 55 (03) :313-316
[7]   Mineralocorticoid receptor knockout mice:: Pathophysiology of Na+ metabolism [J].
Berger, S ;
Bleich, M ;
Schmid, W ;
Cole, TJ ;
Peters, J ;
Watanabe, H ;
Kriz, W ;
Warth, R ;
Greger, R ;
Schütz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9424-9429
[8]   Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor [J].
Bhatnagar, S ;
Sun, LM ;
Raber, J ;
Maren, S ;
Julius, D ;
Dallman, MF .
PHYSIOLOGY & BEHAVIOR, 2004, 81 (04) :545-555
[9]   Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat [J].
Bhattacharya, SK ;
Chakrabarti, A ;
Sandler, M ;
Glover, V .
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (02) :199-206
[10]   GABAergic dysfunction in mood disorders [J].
Brambilla, P ;
Perez, J ;
Barale, F ;
Schettini, G ;
Soares, JC .
MOLECULAR PSYCHIATRY, 2003, 8 (08) :721-737